FDA Import Refusal 799-8672101-6/11/1 — Santen Pharmaceutical Co., Ltd.
The FDA refused shipment 799-8672101-6/11/1 from Santen Pharmaceutical Co., Ltd. (Japan) on Jun 2, 2022. The refused product falls under Drugs and Biologics — NEOSTIGMINE METHYLSULFATE (CHOLINERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 2, 2022
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 63NDK08 NEOSTIGMINE METHYLSULFATE (CHOLINERGIC)
- Charges
- 75